Abstract

This study assessed the safety and efficacy of intravenous adenosine used as a coronary vasodilator in 18 pediatric patients with aortic valve disease or Kawasaki disease. Adenosine infusion effectively produced coronary vasodilation and was well tolerated.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call